Skip to main content
. 2011 Nov;55(11):5338–5346. doi: 10.1128/AAC.00619-11

Fig. 2.

Fig. 2.

RC-101 is bactericidal toward both nasal carriage and clinical isolates of S. aureus. Shown are growth rate data from three nasal carriage isolates (D20-7, D30, and D535-6) and one clinical isolate (USA300) of S. aureus in the presence and absence of RC-101. (Top) RC-101 treatment for 0 to 3 h; (bottom) RC-101 treatment for 3 to 9 h. Limit of detection equals 200 (i.e., log10 = 2.3) CFU/ml. n ≥ 3 for all strains. Values are means ± standard errors of the means (SEM) (error bars). * indicates the starting inoculum. #, P < 0.05; ##, P < 0.01; ###, P < 0.001. P values indicate statistical significance compared to vehicle-treated samples. For clarity of presentation, P values are shown for 3- and 9-h treatments only.